Cargando…

Sustainable reduction of antibiotic-induced antimicrobial resistance (ARena) in German ambulatory care: study protocol of a cluster randomised trial

BACKGROUND: Despite many initiatives to enhance the rational use of antibiotics, there remains substantial room for improvement. The overall aim of this study is to optimise the appropriate use of antibiotics in German ambulatory care in patients with acute non-complicated infections (respiratory tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamradt, Martina, Kaufmann-Kolle, Petra, Andres, Edith, Brand, Tonia, Klingenberg, Anja, Glassen, Katharina, Poß-Doering, Regina, Uhlmann, Lorenz, Hees, Katharina, Weber, Dorothea, Gutscher, Andreas, Wambach, Veit, Szecsenyi, Joachim, Wensing, Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5800289/
https://www.ncbi.nlm.nih.gov/pubmed/29402306
http://dx.doi.org/10.1186/s13012-018-0722-0
_version_ 1783298185607774208
author Kamradt, Martina
Kaufmann-Kolle, Petra
Andres, Edith
Brand, Tonia
Klingenberg, Anja
Glassen, Katharina
Poß-Doering, Regina
Uhlmann, Lorenz
Hees, Katharina
Weber, Dorothea
Gutscher, Andreas
Wambach, Veit
Szecsenyi, Joachim
Wensing, Michel
author_facet Kamradt, Martina
Kaufmann-Kolle, Petra
Andres, Edith
Brand, Tonia
Klingenberg, Anja
Glassen, Katharina
Poß-Doering, Regina
Uhlmann, Lorenz
Hees, Katharina
Weber, Dorothea
Gutscher, Andreas
Wambach, Veit
Szecsenyi, Joachim
Wensing, Michel
author_sort Kamradt, Martina
collection PubMed
description BACKGROUND: Despite many initiatives to enhance the rational use of antibiotics, there remains substantial room for improvement. The overall aim of this study is to optimise the appropriate use of antibiotics in German ambulatory care in patients with acute non-complicated infections (respiratory tract infections, such as bronchitis, sinusitis, tonsillitis and otitis media), community-acquired pneumonia and non-complicated cystitis, in order to counter the advancing antimicrobial resistance development. METHODS: A three-armed cluster randomised trial will be conducted in 14 practice networks in two German federal states (Bavaria and North Rhine-Westphalia) and an added cohort that reflects standard care. The trial is accompanied by a process evaluation. Each arm will receive a different set of implementation strategies. Arm A receives a standard set, comprising of e-learning on communication with patients and quality circles with data-based feedback for physicians, information campaigns for the public, patient information material and performance-based additional reimbursement. Arm B receives this standard set plus e-learning on communication with patients and quality circles with data-based feedback tailored for non-physician health professionals of the practice team and information material for tablet computers (culture sensitive). Arm C receives the standard set as well as a computerised decision support system and quality circles in local multidisciplinary groups. The study aims to recruit 193 practices which will provide data on 23,934 patients each year (47,867 patients in total). The outcome evaluation is based on claims data and refers to established indicators of the European Surveillance of Antimicrobial Consumption Network (ESAC-Net). Primary and secondary outcomes relate to prescribing of antibiotics, which will be analysed in multivariate regression models. The process evaluation is based on interviews with surveys among physicians, non-physician health professionals of the practice team and stakeholders. A patient survey is conducted in one of the study arms. Interview data will be qualitatively analysed using thematic framework analysis. Survey data of physicians, non-physician health professionals of the practice team and patients will use descriptive and exploratory statistics for analysis. DISCUSSION: The ARena trial will examine the effectiveness of large scale implementation strategies and explore their delivery in routine practice. TRIAL REGISTRATION: ISRCTN, ISRCTN58150046. Registered 24 August 2017. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13012-018-0722-0) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5800289
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-58002892018-02-13 Sustainable reduction of antibiotic-induced antimicrobial resistance (ARena) in German ambulatory care: study protocol of a cluster randomised trial Kamradt, Martina Kaufmann-Kolle, Petra Andres, Edith Brand, Tonia Klingenberg, Anja Glassen, Katharina Poß-Doering, Regina Uhlmann, Lorenz Hees, Katharina Weber, Dorothea Gutscher, Andreas Wambach, Veit Szecsenyi, Joachim Wensing, Michel Implement Sci Study Protocol BACKGROUND: Despite many initiatives to enhance the rational use of antibiotics, there remains substantial room for improvement. The overall aim of this study is to optimise the appropriate use of antibiotics in German ambulatory care in patients with acute non-complicated infections (respiratory tract infections, such as bronchitis, sinusitis, tonsillitis and otitis media), community-acquired pneumonia and non-complicated cystitis, in order to counter the advancing antimicrobial resistance development. METHODS: A three-armed cluster randomised trial will be conducted in 14 practice networks in two German federal states (Bavaria and North Rhine-Westphalia) and an added cohort that reflects standard care. The trial is accompanied by a process evaluation. Each arm will receive a different set of implementation strategies. Arm A receives a standard set, comprising of e-learning on communication with patients and quality circles with data-based feedback for physicians, information campaigns for the public, patient information material and performance-based additional reimbursement. Arm B receives this standard set plus e-learning on communication with patients and quality circles with data-based feedback tailored for non-physician health professionals of the practice team and information material for tablet computers (culture sensitive). Arm C receives the standard set as well as a computerised decision support system and quality circles in local multidisciplinary groups. The study aims to recruit 193 practices which will provide data on 23,934 patients each year (47,867 patients in total). The outcome evaluation is based on claims data and refers to established indicators of the European Surveillance of Antimicrobial Consumption Network (ESAC-Net). Primary and secondary outcomes relate to prescribing of antibiotics, which will be analysed in multivariate regression models. The process evaluation is based on interviews with surveys among physicians, non-physician health professionals of the practice team and stakeholders. A patient survey is conducted in one of the study arms. Interview data will be qualitatively analysed using thematic framework analysis. Survey data of physicians, non-physician health professionals of the practice team and patients will use descriptive and exploratory statistics for analysis. DISCUSSION: The ARena trial will examine the effectiveness of large scale implementation strategies and explore their delivery in routine practice. TRIAL REGISTRATION: ISRCTN, ISRCTN58150046. Registered 24 August 2017. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13012-018-0722-0) contains supplementary material, which is available to authorized users. BioMed Central 2018-02-05 /pmc/articles/PMC5800289/ /pubmed/29402306 http://dx.doi.org/10.1186/s13012-018-0722-0 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Study Protocol
Kamradt, Martina
Kaufmann-Kolle, Petra
Andres, Edith
Brand, Tonia
Klingenberg, Anja
Glassen, Katharina
Poß-Doering, Regina
Uhlmann, Lorenz
Hees, Katharina
Weber, Dorothea
Gutscher, Andreas
Wambach, Veit
Szecsenyi, Joachim
Wensing, Michel
Sustainable reduction of antibiotic-induced antimicrobial resistance (ARena) in German ambulatory care: study protocol of a cluster randomised trial
title Sustainable reduction of antibiotic-induced antimicrobial resistance (ARena) in German ambulatory care: study protocol of a cluster randomised trial
title_full Sustainable reduction of antibiotic-induced antimicrobial resistance (ARena) in German ambulatory care: study protocol of a cluster randomised trial
title_fullStr Sustainable reduction of antibiotic-induced antimicrobial resistance (ARena) in German ambulatory care: study protocol of a cluster randomised trial
title_full_unstemmed Sustainable reduction of antibiotic-induced antimicrobial resistance (ARena) in German ambulatory care: study protocol of a cluster randomised trial
title_short Sustainable reduction of antibiotic-induced antimicrobial resistance (ARena) in German ambulatory care: study protocol of a cluster randomised trial
title_sort sustainable reduction of antibiotic-induced antimicrobial resistance (arena) in german ambulatory care: study protocol of a cluster randomised trial
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5800289/
https://www.ncbi.nlm.nih.gov/pubmed/29402306
http://dx.doi.org/10.1186/s13012-018-0722-0
work_keys_str_mv AT kamradtmartina sustainablereductionofantibioticinducedantimicrobialresistancearenaingermanambulatorycarestudyprotocolofaclusterrandomisedtrial
AT kaufmannkollepetra sustainablereductionofantibioticinducedantimicrobialresistancearenaingermanambulatorycarestudyprotocolofaclusterrandomisedtrial
AT andresedith sustainablereductionofantibioticinducedantimicrobialresistancearenaingermanambulatorycarestudyprotocolofaclusterrandomisedtrial
AT brandtonia sustainablereductionofantibioticinducedantimicrobialresistancearenaingermanambulatorycarestudyprotocolofaclusterrandomisedtrial
AT klingenberganja sustainablereductionofantibioticinducedantimicrobialresistancearenaingermanambulatorycarestudyprotocolofaclusterrandomisedtrial
AT glassenkatharina sustainablereductionofantibioticinducedantimicrobialresistancearenaingermanambulatorycarestudyprotocolofaclusterrandomisedtrial
AT poßdoeringregina sustainablereductionofantibioticinducedantimicrobialresistancearenaingermanambulatorycarestudyprotocolofaclusterrandomisedtrial
AT uhlmannlorenz sustainablereductionofantibioticinducedantimicrobialresistancearenaingermanambulatorycarestudyprotocolofaclusterrandomisedtrial
AT heeskatharina sustainablereductionofantibioticinducedantimicrobialresistancearenaingermanambulatorycarestudyprotocolofaclusterrandomisedtrial
AT weberdorothea sustainablereductionofantibioticinducedantimicrobialresistancearenaingermanambulatorycarestudyprotocolofaclusterrandomisedtrial
AT gutscherandreas sustainablereductionofantibioticinducedantimicrobialresistancearenaingermanambulatorycarestudyprotocolofaclusterrandomisedtrial
AT wambachveit sustainablereductionofantibioticinducedantimicrobialresistancearenaingermanambulatorycarestudyprotocolofaclusterrandomisedtrial
AT szecsenyijoachim sustainablereductionofantibioticinducedantimicrobialresistancearenaingermanambulatorycarestudyprotocolofaclusterrandomisedtrial
AT wensingmichel sustainablereductionofantibioticinducedantimicrobialresistancearenaingermanambulatorycarestudyprotocolofaclusterrandomisedtrial